N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143844 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O2 |
| Mol.Wt. | 427.89 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143845 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143846 |
| CAS No | NA |
| Mol.F. | C22H24ClN7O2 |
| Mol.Wt. | 453.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143847 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143848 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143849 |
| CAS No | NA |
| Mol.F. | C20H23ClN8O2 |
| Mol.Wt. | 442.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143850 |
| CAS No | NA |
| Mol.F. | C22H26ClN7O3 |
| Mol.Wt. | 471.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143851 |
| CAS No | NA |
| Mol.F. | C22H26ClN7O3 |
| Mol.Wt. | 471.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143852 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O3 |
| Mol.Wt. | 443.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143853 |
| CAS No | NA |
| Mol.F. | C23H29ClN8O2 |
| Mol.Wt. | g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143854 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143855 |
| CAS No | NA |
| Mol.F. | C11H19N3O5 |
| Mol.Wt. | 273.29 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143856 |
| CAS No | NA |
| Mol.F. | C18H25N3O5 |
| Mol.Wt. | 363.41g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143857 |
| CAS No | NA |
| Mol.F. | C7H5D2ClN4O5S2 |
| Mol.Wt. | 328.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143858 |
| CAS No | NA |
| Mol.F. | C613CH7ClN4O5S2 |
| Mol.Wt. | 327.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143859 |
| CAS No | NA |
| Mol.F. | C613CH5D2ClN215N2O5S2 |
| Mol.Wt. | 331.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |